Why PharmEasy bought Thyrocare
SUBSCRIBE
Thank you for subscribing to Morning Dispatch
We ll soon meet in your inbox. / Morning Dispatch
PharmEasy, forked out Rs 4,546 crore for a controlling stake in diagnostics firm
Thyrocare last week, becoming the first startup unicorn to acquire a listed legacy company in India. We spoke to Siddharth Shah, co-founder and CEO of API Holdings, on why he decided to buy, and to Arokiaswamy Velumani, promoter of Thyrocare, on why he decided to sell.
Also in this letter:
How Covid changed CEO salaries
Google files first report under IT rules
️ The Rundown by ETtech, our weekly Clubhouse chat show, is back for Season 2!